Showing results (1621-1630 of 1,686) with videos related to

Sort By:
Pageof 169
Circulation|May 29, 2008
Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery diseaseMark Y Chan, Mauricio G Cohen, Christopher K Dyke, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 11, 2026
Redefining the norms: an interdisciplinary perspective on language testing in multilinguals with acquired and progressive neurogenic disordersAlessa Hausmann, Adolfo M García, Ana Sofia Costa, et al.
Blood|February 26, 2025
Magrolimab plus azacitidine vs physician's choice for untreated TP53-mutated acute myeloid leukemia: the ENHANCE-2 studyJoshua F Zeidner, David A Sallman, Christian Récher, et al.
Structural Heart : the Journal of the Heart Team|January 21, 2026
Outcomes of Mitral Transcatheter Edge-to-Edge Repair in Patients With Small Mitral Valve AreaChloe Kharsa, Yasser M Sammour, Rasha Bazari, et al.
JAMA|August 12, 2004
Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trialA Michael Lincoff, Neal S Kleiman, Dean J Kereiakes, et al.
Biomedical Reports|February 14, 2018
Topical 5% potassium permanganate solution accelerates the healing process in chronic diabetic foot ulcersIván Delgado-Enciso, Violeta M Madrigal-Perez, Agustin Lara-Esqueda, et al.
Journal of the American College of Cardiology|March 25, 2014
Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgeryJeffrey J Popma, David H Adams, Michael J Reardon, et al.
The New England Journal of Medicine|November 17, 2009
Platelet inhibition with cangrelor in patients undergoing PCIRobert A Harrington, Gregg W Stone, Steven McNulty, et al.
JAMA|February 18, 2003
Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trialA Michael Lincoff, John A Bittl, Robert A Harrington, et al.
Archives of Internal Medicine|January 16, 2008
Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapyGustavo B F Oliveira, Eric M Crespo, Richard C Becker, et al.
Pageof 169